Skip to Content

NVR LCL (Afinitor 2.5 mg)

Generic Name: everolimus

Pill with imprint NVR LCL is White, Capsule-shape and has been identified as Afinitor 2.5 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma (and more), and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR LCL

Afinitor 2.5 mg NVR LCL

Afinitor

Generic Name:
everolimus
Imprint:
NVR LCL
Strength:
2.5 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
MTOR inhibitors
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals Corporation
Inactive Ingredients:
butylated hydroxytoluene
crospovidone
hypromelloses
lactose anhydrous
lactose monohydrate
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide